Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Tolerability, Compliance and Indications of Aspirin Protect 100 mg in Longterm Use (12 Months) Under Everyday's Conditions - Data Collection With Questionnaires Handed Out in Pharmacies to Aspirin Protect 100 mg Consumers

NCT01669824 is registered in ClinicalTrials.gov with Bayer as lead sponsor.

NCT NCT01669824
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01669824 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Tolerability, Compliance and Indications of Aspirin Protect 100 mg in Longterm Use (12 Months) Under Everyday's Conditions - Data Collection With Questionnaires Handed Out in Pharmacies to Aspirin Protect 100 mg Consumers
Lead sponsor
Bayer
Phase
Observational
Overall status
Completed
Start date
August 31, 2007
Completion date
May 31, 2009
Enrollment
4,235 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

aspirin, drug safety, effects, longterm